Update on pancreatic cancer – What health professionals need to know

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • Pancreatic cancer accounts for about 3% of all newly diagnosed cancers and yet was the 3rd most common cause of cancer death last year
  • Early diagnosis is vital, and we must maintain a high index of suspicion and investigate patients with unintended weight loss, non-specific GI symptoms with a history of smoking, obesity, Type 2 Diabetes Mellitus, alcohol ingestion with a CT scan
  • We need to ensure we enlist appropriate help and support for the patient at the time of discharge
  • We cannot assume the patient had been initiated on pancreatic enzyme replacement or that they are taking enough of it
  • Despite the poor prognosis, there may be a silver lining to this dark cloud

Guest: Prof John Zalcberg, Medical Oncologist and Clinician Scientist
Host: Dr David Lim, GP and Medical Educator
Total time: 43 mins

Last Updated: 13 Feb, 2023

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof John Zalcberg

expert

Prof John Zalcberg

Medical Oncologist and Clinician Scientist, Alfred Health; Professor of Cancer Research; School of Public Health; Monash University

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease